Filed in archive
Treatment
by kevin on September 10, 2005
The FDA panel endorses a new class of oral diabetes medication:
A day after recommending the first inhaled form of insulin to treat diabetes, a Food and drug Administration advisory panel on Friday endorsed a new pill that helps control blood sugar levels as well as cholesterol in people with the most common form of the condition.More information on this class of medication can be found here.
The drug, muraglitazar, will be marketed under the name Pargluva. It was developed by Bristol-Myers Squibb and Merck & Co. A joint statement from the companies said they would conduct extensive monitoring of people using the drug to ensure it causes no long-term problems.
The non-insulin treatment is designed for people with Type 2 diabetes, the most common form of the condition that occurs most often in adults who are overweight.
Permalink: A new class of diabetes medication
Tags:
diabetes
medication
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9157
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for A new class of diabetes medication:
|
Rating: 8.00 out of 1 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
